1. A Randomized, Placebo-controlled, Double-blind Pilot Study of Single-dose Humanized Anti-IL5 Antibody (Reslizumab) for the Reduction of Eosinophilia Following Diethylcarbamazine Treatment of Loa loa Infection. (10th September 2020) Authors: Legrand, Fanny; Herrick, Jesica; Makiya, Michelle; Ramanathan, Roshan; Thompson, Reagan; Rampertaap, Shakuntala; Stoddard, Jennifer; Ware, JeanAnne; Fay, Michael P; Holland-Thomas, Nicole; Nutman, Thomas B; Klion, Amy D Journal: Clinical infectious diseases Issue: Volume 73:Number 7(2021) Page Start: e1624 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mechanisms of glucocorticoid resistance in hypereosinophilic syndromes. Issue 12 (27th October 2019) Authors: Stokes, Kindra; Yoon, Pryscilla; Makiya, Michelle; Gebreegziabher, Meheret; Holland‐Thomas, Nicole; Ware, JeanAnne; Wetzler, Lauren; Khoury, Paneez; Klion, Amy D. Journal: Clinical & experimental allergy Issue: Volume 49:Issue 12(2019) Page Start: 1598 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗